Works by KIM, JIN‐SEOK


Results: 225
    1

    Variation in immunoglobulin use and impact on survival in myeloma.

    Published in:
    EJHaem, 2024, v. 5, n. 4, p. 690, doi. 10.1002/jha2.938
    By:
    • Chai, Khai Li;
    • Wellard, Cameron;
    • Thao, LTP;
    • Aoki, Naomi;
    • Moore, Elizabeth M;
    • Augustson, Bradley M;
    • Bapat, Akshay;
    • Blacklock, Hilary;
    • Chng, Wee J;
    • Cooke, Rachel;
    • Forsyth, Cecily J;
    • Goh, Yeow‐Tee;
    • Hamad, Nada;
    • Harrison, Simon J;
    • Ho, P Joy;
    • Hocking, Jay;
    • Kerridge, Ian;
    • Kim, Jin Seok;
    • Kim, Kihyun;
    • King, Tracy
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 1, p. 81, doi. 10.1007/s12185-020-02988-6
    By:
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Mitigating Drug–Target–Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 904, doi. 10.1002/cpt.2851
    By:
    • Nishimura, Jun‐ichi;
    • Soubret, Antoine;
    • Arase, Noriko;
    • Buatois, Simon;
    • Hotta, Masaki;
    • Charoin, Jean‐Eric;
    • Ito, Yoshikazu;
    • Sreckovic, Sasha;
    • Takamori, Hiroyuki;
    • Bucher, Christoph;
    • Ueda, Yasutaka;
    • Hernández‐Sánchez, Jules;
    • Gotanda, Keisuke;
    • Jordan, Gregor;
    • Shinomiya, Kenji;
    • Ramos, Julia;
    • Kim, Jin Seok;
    • Panse, Jens;
    • de Latour, Régis Peffault;
    • Röth, Alexander
    Publication type:
    Article
    35
    36

    Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.

    Published in:
    Cancer Science, 2010, v. 101, n. 11, p. 2443, doi. 10.1111/j.1349-7006.2010.01698.x
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Kim, Seok Jin;
    • Lee, Suee;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Chae, Yee Soo;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Lee, Ho Sup;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok
    Publication type:
    Article
    37
    38
    39

    Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1757, doi. 10.1002/ajh.27413
    By:
    • Scheinberg, Phillip;
    • Clé, Diego Villa;
    • Kim, Jin Seok;
    • Nur, Erfan;
    • Yenerel, Mustafa N.;
    • Barcellini, Wilma;
    • Bonito, Debora;
    • Giai, Valentina;
    • Hus, Marek;
    • Lee, YooJin;
    • Lekue, Cristina Barrenetxea;
    • Panse, Jens;
    • Ueda, Yasutaka;
    • Buatois, Simon;
    • Gentile, Brittany;
    • Kiialainen, Anna;
    • Patel, Himika;
    • Sreckovic, Sasha;
    • Uguen, Marianne;
    • Edwards, John
    Publication type:
    Article
    40

    Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
    By:
    • Cho, Hyungwoo;
    • Yoon, Dok Hyun;
    • Lee, Jung Bok;
    • Kim, Sung-Yong;
    • Moon, Joon Ho;
    • Do, Young Rok;
    • Lee, Jae Hoon;
    • Park, Yong;
    • Lee, Ho Sup;
    • Eom, Hyeon Seok;
    • Shin, Ho-Jin;
    • Min, Chang-Ki;
    • Kim, Jin Seok;
    • Jo, Jae-Cheol;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Lee, Je-Jung;
    • Suh, Cheolwon;
    • Kim, Kihyun
    Publication type:
    Article
    41

    Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 7, p. 751, doi. 10.1002/ajh.23731
    By:
    • Kim, Kihyun;
    • Lee, Jae Hoon;
    • Kim, Jin Seok;
    • Min, Chang Ki;
    • Yoon, Sung Soo;
    • Shimizu, Kazuyuki;
    • Chou, Takaaki;
    • Kosugi, Hiroshi;
    • Suzuki, Kenshi;
    • Chen, Wenming;
    • Hou, Jian;
    • Lu, Jin;
    • Huang, Xiao-Jun;
    • Huang, Shang-Yi;
    • Chng, Wee Joo;
    • Tan, Daryl;
    • Teoh, Gerrard;
    • Chim, Chor Sang;
    • Nawarawong, Weerasak;
    • Siritanaratkul, Noppadol
    Publication type:
    Article
    42
    43

    Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases.

    Published in:
    American Journal of Hematology, 2009, v. 84, n. 12, p. 826, doi. 10.1002/ajh.21557
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Seok Jin;
    • Kim, Jin Seok;
    • Kim, Sung-Hyun;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Kim, Jong Gwang;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Choi, Young Jin;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Suh, Cheolwon;
    • Kim, Hyo-Jin
    Publication type:
    Article
    44
    45

    Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
    By:
    • Kaufman, Jonathan L.;
    • Dimopoulos, Meletios A.;
    • White, Darrell;
    • Benboubker, Lotfi;
    • Cook, Gordon;
    • Leiba, Merav;
    • Morton, James;
    • Joy Ho, P.;
    • Kim, Kihyun;
    • Takezako, Naoki;
    • Moreau, Philippe;
    • Sutherland, Heather J.;
    • Magen, Hila;
    • Iida, Shinsuke;
    • Kim, Jin Seok;
    • Miles Prince, H.;
    • Cochrane, Tara;
    • Oriol, Albert;
    • Bahlis, Nizar J.;
    • Chari, Ajai
    Publication type:
    Article
    46

    Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0245-1
    By:
    • Soekojo, Cinnie Yentia;
    • Kim, Kihyun;
    • Huang, Shang-Yi;
    • Chim, Chor-Sang;
    • Takezako, Naoki;
    • Asaoku, Hideki;
    • Kimura, Hideo;
    • Kosugi, Hiroshi;
    • Sakamoto, Junichi;
    • Gopalakrishnan, Sathish Kumar;
    • Nagarajan, Chandramouli;
    • Wei, Yuan;
    • Moorakonda, Rajesh;
    • Lee, Shu Ling;
    • Lee, Je Jung;
    • Yoon, Sung-Soo;
    • Kim, Jin Seok;
    • Min, Chang Ki;
    • Lee, Jae-Hoon;
    • Durie, Brian
    Publication type:
    Article
    47
    48
    49
    50